An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis

NCT03229252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Placebo Inhalation Solution
DRUG: SPX-101

Sponsor

Spyryx Biosciences, Inc.